- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05446441
Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma
June 30, 2022 updated by: Minghua Ge, Zhejiang Provincial People's Hospital
Endoscopic Thyroidectomy Using Gasless Unilateral Transaxillary Approach Versus Conventional Open Thyroidectomy for Papillary Thyroid Cancer: a Prospective, Multicenter, Randomized Controlled Clinical Trial
Recently, endoscopic thyroidectomy using gasless unilateral transaxillary approach has been proven feasible and safe in several Chinese medical centers.
This study is aimed to compare multi-institutional Chinese outcomes of endoscopic thyroidectomy using gasless unilateral transaxillary approach and conventional open surgery.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Most patients with thyroid tumors are effectively treated surgically by practitioners experienced in the techniques of thyroidectomy.
Many patients, especially women, undergoing thyroid surgery are concerned about the postoperative cosmetic appearance of the neck.
Endoscopic thyroidectomy using gasless unilateral transaxillary approach which can hide the operative scar was associated with a higher degree of patient cosmetic satisfaction.
Recently, endoscopic thyroidectomy using gasless unilateral transaxillary approach has been proven feasible and safe in several Chinese medical centers.
In this study, we designed a prospective study comparing multi-institutional Chinese outcomes of endoscopic thyroidectomy using gasless unilateral transaxillary approach and conventional open surgery.
Study Type
Interventional
Enrollment (Anticipated)
634
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Minghua Ge, Doctor
- Phone Number: 86057185335800 86057187666666
- Email: geminghua@hmc.edu.cn
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 18 years;
- The pathological type is papillary thyroid carcinoma;
- Tumor diameter <2 cm;
- No extraglandular invasion, or minimal extrathyroidal extension invading only anterior thyroid capsule or sternothyoid muscle;
- cN0 or cN+ without fusion and fixation of metastatic lymph nodes;
- no obvious contraindication for thyroidectomy ;
- Good comply with the research visit plan and other program requirements;
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:
- patients with severe systemic diseases who can not tolerate general anesthesia or routine surgical posture;
- previous history of neck surgery, radiotherapy or thermal ablation;
- hyperthyroidism and substernal goiter;
- dedifferentiated thyroid carcinoma;
- accompanied with severe thyroiditis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention;
Endoscopic thyroidectomy was performed in a standardized fashion by multi-institutional Chinese experienced surgeons using the same gasless unilateral transaxillary approach.
|
Endoscopic thyroidectomy group is the papillary thyroid carcinoma patient group who underwent endoscopic thyroid surgery using a gasless, trans-axillary approach.
|
|
Active Comparator: Control
Conventional open surgery was performed in a standardized fashion by multi-institutional Chinese experienced surgeons.
|
Endoscopic thyroidectomy group is the papillary thyroid carcinoma patient group who underwent endoscopic thyroid surgery using a gasless, trans-axillary approach.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of retrieved central lymph nodes
Time Frame: 1 month after operation
|
The number of central lymph nodes removed during the operation
|
1 month after operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Minghua Ge, Doctor, Zhejiang Provincial People's Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 28, 2022
Primary Completion (Anticipated)
August 31, 2023
Study Completion (Anticipated)
August 31, 2025
Study Registration Dates
First Submitted
June 30, 2022
First Submitted That Met QC Criteria
June 30, 2022
First Posted (Actual)
July 6, 2022
Study Record Updates
Last Update Posted (Actual)
July 6, 2022
Last Update Submitted That Met QC Criteria
June 30, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022(050)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Cancer
-
National Cancer Institute (NCI)TerminatedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Anaplastic Thyroid Cancer | Stage III Follicular Thyroid Cancer | Stage III Papillary Thyroid CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI); GlaxoSmithKline; National Comprehensive Cancer...CompletedRecurrent Thyroid Cancer | Stage IVA Follicular Thyroid Cancer | Stage IVA Papillary Thyroid Cancer | Stage IVB Follicular Thyroid Cancer | Stage IVB Papillary Thyroid Cancer | Stage IVC Follicular Thyroid Cancer | Stage IVC Papillary Thyroid CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Cancer | Stage IVA Follicular Thyroid Cancer | Stage IVA Papillary Thyroid Cancer | Stage IVB Follicular Thyroid Cancer | Stage IVB Papillary Thyroid Cancer | Stage IVC Follicular Thyroid Cancer | Stage IVC Papillary Thyroid CancerUnited States
-
University of PennsylvaniaCompletedMetastatic Medullary Thyroid Cancer | Metastatic Differentiated Thyroid Cancer | Metastatic Anaplastic Thyroid Cancer | Metastatic Poorly Differentiated Thyroid CancerUnited States
-
Children's Hospital of PhiladelphiaEli Lilly and Company; United States Department of DefenseRecruitingCancer | Pediatric Cancer | Differentiated Thyroid Cancer | Cancer, ThyroidUnited States
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
-
Children's Hospital of PhiladelphiaBayerRecruitingCancer | Pediatric Cancer | Differentiated Thyroid Cancer | Cancer, ThyroidUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingThyroid Cancer, Follicular | Thyroid Cancer | Papillary Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid Cancer | Hurthle Cell Tumor | Hurthle Cell Thyroid NeoplasiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedThyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid CancerUnited States
Clinical Trials on Endoscopic surgery;
-
State University of New York - Upstate Medical...TerminatedChronic Sinusitis | Adenoid Disease - ChronicUnited States
-
Helsinki University Central HospitalCompletedAsthma | Nasal Polyps | Aspirin Sensitivity | Sinusitis, ChronicFinland, Netherlands
-
Beijing Tongren HospitalCompletedChronic Rhinosinusitis (Diagnosis) | Surgery
-
Universitaire Ziekenhuizen KU LeuvenRecruitingPituitary Adenoma | Meningioma | Craniopharyngioma | Pituitary Disease | Olfactory Dysfunction | Endoscopic Pituitary SurgeryBelgium, Germany, Netherlands
-
University of Sao Paulo General HospitalUnknownDysphagia | AchalasiaBrazil
-
Qilu Hospital of Shandong UniversityRecruitingComparision of Endoscopic Discectomy and Microdiscectomy for the Treatment of Lumbar Spinal StenosisLumbar Spinal StenosisChina
-
Al-Azhar UniversityCompletedEndoscopic Sinus Surgery | Navigation | Computer Assisted | Sinonasal PolyposisEgypt
-
Eye & ENT Hospital of Fudan UniversityRecruitingSurgery | Sarcoma,Soft Tissue | Paranasal Sinus Cancer | Nasal Cavity CancerChina
-
AO Clinical Investigation and Publishing DocumentationCompletedCondylar Neck FracturesGermany
-
University Hospitals Cleveland Medical CenterCompletedProstatic Diseases | Gastric Foreign Body, Nos | Disorder of Abdomen (Disorder) | Foreign Body in Esophagus | Disease of Small IntestineUnited States